Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The coronavirus disease 2019 (COVID-19) pandemic has impacted the medical, social, and reproductive health of millions of people since its outbreak. The causative virus transmits, reproduces, and manifests through the respiratory tract. COVID-19 can invade any system of the body, including the cardiovascular and endocrine systems, through a secondary immune response. In particular, because the fatality rate is high in those over the age of 50 years, special attention is required during the medical care of this population. However, considering the benefit of therapy and the risk of COVID-19, high-quality evidence regarding individualized management in relation to hormone therapy is still insufficient in the field of gynecology. Furthermore, this review aims to serve as a reference for clinical application by analyzing and summarizing the results of studies reported to date regarding female hormone therapy in the context of the COVID-19 pandemic.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has impacted the medical, social, and reproductive health of millions of people since its outbreak. The causative virus transmits, reproduces, and manifests through the respiratory tract. COVID-19 can invade any system of the body, including the cardiovascular and endocrine systems, through a secondary immune response. In particular, because the fatality rate is high in those over the age of 50 years, special attention is required during the medical care of this population. However, considering the benefit of therapy and the risk of COVID-19, high-quality evidence regarding individualized management in relation to hormone therapy is still insufficient in the field of gynecology. Furthermore, this review aims to serve as a reference for clinical application by analyzing and summarizing the results of studies reported to date regarding female hormone therapy in the context of the COVID-19 pandemic.
참고문헌 (46)
- Adam BD, "The effort to count the pandemic’s global death toll", Nature, 601, pp.312~315 (2022)
- Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention", Nat Rev Immunol, 20, pp.363~374 (2020)
- O'Driscoll M, "Age-specific mortality and immunity patterns of SARS-CoV-2", Nature, 590, pp.140~145 (2021)
- Channappanavar R, "Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection", J Immunol, 198, pp.4046~4053 (2017)
- McCoy J, "Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?", J Cosmet Dermatol, 19, pp.1542~1543 (2020)
- Park CY, "Evaluation of menopausal hormone therapy use in Korea(2002-2013) : a nationwide cohort study", Maturitas, 146, pp.57~62 (2021)
- Mauvais-Jarvis F, "The role of estrogens in control of energy balance and glucose homeostasis", Endocr Rev, 34, pp.309~338 (2013)
- Taneja V, "Sex hormones determine immune response", Front Immunol, 9, pp.1931~ (2018)
- Kim JE, "A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases", Sci Rep, 10, pp.20631~ (2020)
- Wang XW, "Association of menopausal status with COVID-19 outcomes : a propensity score matching analysis", Biol Sex Differ, 12, pp.16~ (2021)
- O'Brien J, "Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age", J Ovarian Res, 13, pp.137~ (2020)
- Her AY, "Sex-specific difference of in-hospital mortality from COVID-19 in South Korea", PLoS One, 17, pp.e0262861~ (2022)
- Seeland U, "Evidence for treatment with estradiol for women with SARSCoV-2 infection", BMC Med, 18, pp.369~ (2020)
- Li K, "Analysis of sex hormones and menstruation in COVID-19 women of childbearing age", Reprod Biomed Online, 42, pp.260~267 (2021)
- Newson L, "Long Covid and menopause-the important role of hormones in Long Covid must be considered", Maturitas, 152, pp.74~ (2021)
- Straub RH, "The complex role of estrogens in inflammation", Endocr Rev, 28, pp.521~574 (2007)
- Ramírez-de-Arellano A, "The role of estradiol in the immune response against COVID-19", Hormones (Athens), 20, pp.657~667 (2021)
- Culebras E, "ACE2 is on the X chromosome: could this explain COVID-19 gender differences?", Eur Heart J, 41, pp.3095~ (2020)
- Stelzig KE, "Estrogen regulates the expression of SARSCoV-2 receptor ACE2 in differentiated airway epithelial cells", Am J Physiol Lung Cell Mol Physiol, 318, pp.L1280~L1281 (2020)
- Li Y, "Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor", Pharmacol Res, 157, pp.104833~ (2020)
- Ciarambino T, "Immune system and COVID-19 by sex differences and age", Womens Health(Lond), 17, pp.17455065211022262~ (2021)
- Lei Y, "SARSCoV-2 spike protein impairs endothelial function via downregulation of ACE2", Circ Res, 128, pp.1323~1326 (2021)
- Zhang L, "ACE2 in the second act of COVID-19 syndrome : peptide dysregulation and possible correction with oestrogen", J Neuroendocrinol, 33, pp.e12935~ (2021)
- Spiering AE, "Why females do better : the X chromosomal TLR7 gene-dose effect in COVID-19", Front Immunol, 12, pp.756262~ (2021)
- Sund M, "Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19 : a cohort study", BMJ Open, 12, pp.e053032~ (2022)
- Maglione A, "The adaptive immune system in multiple sclerosis : an estrogen-mediated point of view", Cells, 8, pp.1280~ (2019)
- Coelingh Bennink HJT, "Treatment of serious COVID-19 with testosterone suppression and high-dose estrogen therapy", Eur Urol, 80, pp.523~525 (2021)
- Shah SB, "COVID-19 and progesterone: part 2. Unraveling high severity, immunity patterns, immunity grading, progesterone and its potential clinical use", Endocr Metab Sci, 5, pp.100110~ (2021)
- Ghandehari S, "Progesterone in addition to standard of care vs standard of care alone in the treatment of men hospitalized with moderate to severe COVID-19 : a randomized, controlled pilot trial", Chest, 160, pp.74~84 (2021)
- Abou-Ismail MY, "Estrogen and thrombosis : a bench to bedside review", Thromb Res, 192, pp.40~51 (2020)
- Cushman M, "Epidemiology and risk factors for venous thrombosis", Semin Hematol, 44, pp.62~69 (2007)
- Wise J, "Covid-19 and thrombosis: what do we know about the risks and treatment?", BMJ, 369, pp.m2058~ (2020)
- Greinacher A, "Thrombotic thrombocytopenia after ChAdOx1 nCov-19vaccination", N Engl J Med, 384, pp.2092~2101 (2021)
- "CDC recommends use of Johnson & Johnson’s Janssen COVID-19 vaccine resume" (2021)[URL]
- "AstraZeneca Covid vaccine: safety and side effects"[URL]
- Canonico M, "Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women : systematic review and meta-analysis", BMJ, 336, pp.1227~1231 (2008)
- Herrington DM, "Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen", Progestin Replacement Study(HERS), 2002, pp.105, 2962~2967
- Post MS, "Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis : a randomized, placebo-controlled study in postmenopausal women", Arterioscler Thromb Vasc Biol, 23, pp.1116~1121 (2003)
- Cagnacci A, "Reflections and recommendations on the COVID-19 pandemic: should hormone therapy be discontinued?", Maturitas, 138, pp.76~77 (2020)
- Ramírez I, "Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic : Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia", Maturitas, 137, pp.57~62 (2020)
- Witt DM, "American Society of Hematology 2018 guidelines for management of venous thromboembolism : optimal management of anticoagulation therapy", Blood Adv, 2, pp.3257~3291 (2018)
- Davey DA, "Menopausal hormone therapy : a better and safer future", Climacteric, 21, pp.454~461 (2018)
- "AstraZeneca’s COVID-19 vaccine:EMA finds possible link to very rare cases of unusual blood clots with low blood platelets" (2021)[URL]
- Rzymski P, "Thrombotic thrombocytopenia after COVID-19 vaccination : in search of the underlying mechanism", Vaccines (Basel), 9, pp.559~ (2021)
- "Update: thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination. Advisory Committee on Immunization Practices (ACIP)" (2021)[URL]
- Taquet M, "Cerebral venous thrombosis and portal vein thrombosis : a retrospective cohort study of 537, 913 COVID-19 cases", EClinicalMedicine, 39, pp.101061~ (2021)
